MULTIPLE SCLEROSIS (MS)
Clinical trials for MULTIPLE SCLEROSIS (MS) explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS (MS) trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS (MS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on Hard-to-Treat brain diseases
Disease control Not yet recruitingThis early-phase study is testing a new treatment called C-CAR168 for people with severe autoimmune diseases affecting the brain and spinal cord, such as multiple sclerosis and autoimmune encephalitis, that have not improved with standard therapies. The treatment uses a patient's…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Phase: PHASE1 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated May 26, 2026 08:57 UTC
-
New immune cell therapy targets MS in first human safety trial
Disease control Not yet recruitingThis early-stage study tests whether a new immune cell treatment called universal STAR-T cells is safe for people with multiple sclerosis (MS). About 24 adults with progressive or relapsing-remitting MS who have no other treatment options will receive the cells in increasing dose…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Phase: PHASE1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Video game training may rewire MS brains, study hopes
Knowledge-focused Not yet recruitingThis study will use brain scans (fMRI) to see if a special video game designed to train thinking skills can change how the brain works in people with multiple sclerosis. About 40 adults with MS who have some thinking problems will play the game, and researchers will compare their…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Phase: NA • Sponsor: Lille Catholic University • Aim: Knowledge-focused
Last updated May 26, 2026 09:02 UTC
-
New MRI technique may clear up confusion in aging MS patients
Knowledge-focused Not yet recruitingThis study looks at whether an advanced MRI method called Quantitative Susceptibility Mapping (QSM) can help doctors tell the difference between multiple sclerosis (MS) lesions and age-related white matter changes in people aged 50-70. About 1,000 participants with MS or small ve…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC